Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:

CoreCard Corporation CCRD: This technology solutions and processing services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

CoreCard Corporation Price and Consensus

CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote

CoreCard’s shares gained 44.9% over the last three months compared with the S&P 500’s advance of 5.3%. The company possesses a Momentum Score  of A.

CoreCard Corporation Price

CoreCard Corporation price | CoreCard Corporation Quote

Entrada Therapeutics, Inc. TRDA: This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.

Entrada Therapeutics, Inc. Price and Consensus

Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote

Entrada’s shares gained 8.8% over the last three months compared with the S&P 500’s advance of 5.3%. The company possesses a Momentum Score of A.

Entrada Therapeutics, Inc. Price

Entrada Therapeutics, Inc. price | Entrada Therapeutics, Inc. Quote

NRx Pharmaceuticals, Inc. NRXP: This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

NRx’s shares gained 11.8% over the past month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

NRx Pharmaceuticals, Inc. Price

NRx Pharmaceuticals, Inc. price | NRx Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report

CoreCard Corporation (CCRD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research